Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options
MetadataShow full item record
AbstractDoes treatment with sofosbuvir for Hepatitis C genotype 2 or 3 patients for whom peginterferon and ribavirin treatment was not an option lead to a sustained virologic response at 12 week weeks after therapy?
AffiliationMedical College of Georgia
DescriptionCritically appraised topic completed as an assignment in Essentials of Clinical Medicine II